Individuals Discontinuing Anti-Obesity Injections Put On Weight Four Times Faster Compared to Dieters

New research suggests that people who come off popular weight-loss injections like Wegovy and Mounjaro may regain lost weight much more quickly than those who stop conventional lifestyle plans.

Findings released in a leading health publication points out that while obese people often shed substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.

"Users using these treatments must be cognizant of the risk of rapid weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

Such speed of recovery implies a return to original weight in about a year and a half.

Analyzing Treatments

The study, which looked at dozens of trials involving thousands of patients, contrasted the results of the injectable medications with older methods.

Scientists note that individuals who lose weight through lifestyle changes alone usually experience a less rapid weight regain—around 0.1 kg a month—after stopping.

Explaining the Rapid Regain

Doctors suggest the mechanism of the jabs is key to understanding the heightened rebound.

These medications copy a natural hormone called GLP-1, which moderates appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement results in appetite is unsuppressed, making binge eating much more probable."

An Ongoing Condition?

Health authorities advise the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts contend that, considering the likelihood of weight regain, the therapy should be considered life-long.

This opinion is echoed by pharmaceutical companies, who say that the results "underscore the chronic nature of obesity," akin to managing diseases like hypertension.

User Accounts

Individuals who have discontinued the jabs report a powerful return of hunger.

"It was like a trigger flipping and you become extremely hungry," described one woman.

This challenge is compounded if individuals have not developed sustainable dietary or behavioural modifications during treatment.

Growing Adoption

Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Use is higher among females compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, experts stress that while these medications are potent tools for shedding pounds, they are not a standalone cure and long-term success likely depends on combined lifestyle management.